Investigation Depo-Provera Brain tumors | Biopharma dive

Washington –

If you have concerns about your use of Depo-Provera, we would like to hear from you. Please fill out the contact form on this page, send us an e -mail at [email protected]Or call us at (202) 470-3520.

Ongoing depot-provera lawsuit

At the beginning of last year, the British Medical Journal published a study in which Depo-Provera increased the risk of developing a kind of brain tumor as a meningioma. This is a kind of tumor that occurs on the meninges, the protective membranes that surround and cover the brain and spinal cord. The study showed that long-term users developed these tumors about 3.5 times more often than those who did not receive Depo-Provera.

In October 2024, Kristina Schmidt filed the first complaint against Pfizer for this product. Schmidt had taken the product for years and claims that after a period of severe headaches and dizziness in 2022, meningioma was diagnosed.

In her lawsuit, Schmidt claims that Pfizer knew or should have known about the risks that deps the Depo-Provera that she and other users should have warned of the medication.

Did you use Depo-Provera?

Have you used Depo-Provera in the past at any time? If so, we would like to hear from you. We examine this medication and try to keep Pfizer and associated parties responsible for the risks that Depo-Provera has suspended their patients.

###